The use of AI in clinical trials can revolutionize the entire drug development process, enabling more efficient data management, improved decision-making, and overall success of the clinical trial value chain. Here are some of the most prominent use cases of AI in clinical trials: Automate ...
Decentralised clinical trials improve patient recruitment, retention and representative inclusion, by putting the patient at the centre of clinical trial design. However, every study needs to be assessed for suitability and requires an approach to choose the right service options, technology and framework...
How are Clario’s solutions compatible with my trial needs? Can Clario support us not only in the initial stages but also in the long-term? What if our trial involves novel or complex oncology trial criteria? Talk to a specialist to get started ...
There are several stages, or “phases,” of aclinical trial. Each new phase builds on information from previous stages. You might qualify for a certain phase of a trial because of the state of your health or the seriousness of your particular illness. People who take part usually do it in...
Before an omics test is considered for use in a clinical trial, the assay methods used and the data gathered in the developmental stages should be carefully reviewed to determine whether the version of the assay underlying the omics test being proposed for the trial can be expected to generate...
11. The different characteristics of tissue structure and microenvironment between these organs lead to differences in the fibrotic process (Fig.1). Despite increasing in-depth research on fibrosis, the mechanisms have not been fully explained, thus hindering the advancement of targeted drug research ...
This includes the stages and/or severities of the pathologies, the specific medical conditions, and the specific anatomical locations or confirmation that no anatomical locations are contraindicated, as applicable. The target population(s) shall be specified, for example if the device is intended for...
IDEAL stages 2a and 2b, for example, are described as development and exploratory stages, during which the intervention is refined, operators’ learning curves are analyzed and the influence of patient and operator variability on effectiveness are explored prospectively, before large-scale efficacy ...
This parallels the history of medical statistics which used to be an afterthought but is now integral to the initial stages of clinical trial design. The same is required of a measurement strategy. It is also important not to conflate measurement methods, which concern the generation of ...
The sample size is too small to permit generalizability, but it should provide a window into what a larger trial would look like. The submission should include a descriptive and succinct title, a structured Abstract, an Introduction that specifies the importance of the study, a Methods section,...